Wang, Yadong
Huang, Zhicheng
Li, Bowen
Xue, Jianchao
Guo, Chao
Bing, Zhongxing
Zheng, Zhibo
Song, Yang
Xu, Yuan
Huang, Guanghua
Li, Haochen
Yu, Xiaoqing
Xia, Yankai
Li, Ruirui
Si, Xiaoyan
Zhang, Li
Li, Ji
Song, Lan
Xiong, Yuanyuan
Gu, Dejian
Song, Mengmeng
Zhou, Zhipeng
Chen, Rongrong
Feng, Zhe
Bie, Zhixin
Li, Xiaoguang
Yang, Huaxia
Li, Shanqing
Liang, Naixin
Funding for this research was provided by:
National High Level Hospital Clinical Research Funding (2022-PUMCH-A-106, 2022-PUMCH-B-011, 2022-PUMCH-A-259, 2022-PUMCH-A-188)
the CAMS Initiative for Innovative Medicine (2021-I2M-1-015, 2021-I2M-1-016, 2020-I2M-C&T-B-011)
Chinese Society of Clinical Oncology fund (Y-2019AZMS-0452, Y-MSDPU2021-0190, Y-MSD2020-0270)
Article History
Received: 20 December 2023
Accepted: 14 April 2024
First Online: 26 April 2024
Conflict of interest
: The authors have no relevant financial or non-financial interests to disclose.
: This study involved human participants and was approved by the ethical committee of Peking Union Medical College Hospital (S-K1670).
: Informed consent was obtained from all individual participants included in the study.